e8vk
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of Earliest Event Reported): September 26, 2006
STAAR Surgical Company
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
0-11634
|
|
95-3797439 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
|
|
| 1911 Walker Ave, Monrovia, |
|
|
|
|
| California |
|
|
|
91016 |
|
|
|
|
|
|
| (Address of principal executive offices) |
|
|
|
(Zip Code) |
Registrant’s telephone number, including area code: 626-303-7902
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
|
|
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 7.01 Regulation FD Disclosure.
David Bailey, President and CEO of STAAR Surgical Company, intends to make a slide
presentation at private investor meetings in New York, New York and Boston, Massachusetts on
September 26, 2006 and September 27, 2006, and at the UBS Global Life Sciences Conference s in New
York at 12:30 p.m. local time on September 28, 2006. A copy of the slide presentation is furnished
with this report as Exhibit 99.1.
As STAAR has previously announced, while attendance is by invitation only, an audio-only
webcast of STAAR’s presentation at the UBS Global Life Sciences Conference may be accessed through
the Company’s website at www.staar.com. An archived replay of the presentation will be available
approximately 3 hours after the live presentation and can also be accessed at www.staar.com.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
STAAR Surgical Company
|
|
| September 26, 2006 |
By: |
/s/ David Bailey
|
|
| |
|
Name: |
David Bailey |
|
| |
|
Title: |
President and Chief
Executive Officer |
|
| |
Exhibit Index
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
Slide Presentation, September 26, 2006. |